TrialCirculation2026

Incidence, Risk Factors, and Outcomes in Stressor-Associated Atrial Fibrillation: Insights From the VITAL-AF Trial.

Julian S Haimovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.